AIM: To study the deletion of mitochondiral DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia and its significance in the development of cancer. METHODS: Deleted mtDNA (CD-mtDNA) and wild type mtDNA (WT-mtDNA) were quantitatively analyzed by using real-time PCR in 27 hepatocellular carcinomas (HCC) and corresponding noncancerous liver tissues and 27 hepatocellular nodular hyperplasiae (HNH). RESULTS: A novel CD (4 981 bp) was detected in 85% (23/27) and 83%(22/27) of HCC and HNH tumor tissues, respectively, which were significantly higher than that in paired noncancerous liver tissues (57%, 15/27) (P<0.05). The CD/WT-mtDNA ratio in HCC tumors was 0.00092 (median, interquartile range, 0.0001202-0.00105), which was significantly higher than that in paired noncancerous liver tissues (median, 0.000, quartile range, 0-0) (P=0.002, Mann-Whitney Test), and was 25 of times of that in HNH tissues (median, 0.0000374, quartile range, 0-0.0004225) (P=0.002, Mann-Whitney test). CONCLUSION: CD-mtDNA mutation plays an important role in the development and progression of HCC.
AIM: To study the deletion of mitochondiral DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia and its significance in the development of cancer. METHODS: Deleted mtDNA (CD-mtDNA) and wild type mtDNA (WT-mtDNA) were quantitatively analyzed by using real-time PCR in 27 hepatocellular carcinomas (HCC) and corresponding noncancerous liver tissues and 27 hepatocellular nodular hyperplasiae (HNH). RESULTS: A novel CD (4 981 bp) was detected in 85% (23/27) and 83%(22/27) of HCC and HNH tumor tissues, respectively, which were significantly higher than that in paired noncancerous liver tissues (57%, 15/27) (P<0.05). The CD/WT-mtDNA ratio in HCC tumors was 0.00092 (median, interquartile range, 0.0001202-0.00105), which was significantly higher than that in paired noncancerous liver tissues (median, 0.000, quartile range, 0-0) (P=0.002, Mann-Whitney Test), and was 25 of times of that in HNH tissues (median, 0.0000374, quartile range, 0-0.0004225) (P=0.002, Mann-Whitney test). CONCLUSION: CD-mtDNA mutation plays an important role in the development and progression of HCC.
Authors: Tatiana I Rogounovitch; Vladimir A Saenko; Yuki Shimizu-Yoshida; Aleksandr Yu Abrosimov; Eugeny F Lushnikov; Pavel O Roumiantsev; Akira Ohtsuru; Hiroyuki Namba; Anatoly F Tsyb; Shunichi Yamashita Journal: Cancer Res Date: 2002-12-01 Impact factor: 12.701
Authors: S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young Journal: Nature Date: 1981-04-09 Impact factor: 49.962
Authors: J M Shoffner; M T Lott; A S Voljavec; S A Soueidan; D A Costigan; D C Wallace Journal: Proc Natl Acad Sci U S A Date: 1989-10 Impact factor: 11.205
Authors: S Fukushima; K Honda; M Awane; E Yamamoto; R Takeda; I Kaneko; A Tanaka; T Morimoto; K Tanaka; Y Yamaoka Journal: Hepatology Date: 1995-06 Impact factor: 17.425
Authors: Chuanzhong Ye; Xiao-Ou Shu; Wanqing Wen; Larry Pierce; Regina Courtney; Yu-Tang Gao; Wei Zheng; Qiuyin Cai Journal: Breast Cancer Res Treat Date: 2007-05-31 Impact factor: 4.872
Authors: Abdel Rahman N Zekri; Hosny Salama; Eman Medhat; Sherif Hamdy; Zeinab K Hassan; Yasser Mabrouk Bakr; Amira Salah El - Din Youssef; Doaa Saleh; Ramy Saeed; Dalia Omran Journal: Asian Pac J Cancer Prev Date: 2017-09-27